| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |